Company news

DSM-Firmenich AG news in 2026

DSM-Firmenich AG's news releases, calls and decks from 2026, newest first.

View company

Sustell and SustainCERT partner to connect footprint measurement, verification and carbon registry capabilities

November 4, 2026

Dsm-firmenich Board of Directors proposes Richard Ridinger as new Chairman following Thomas Leysen’s decision to retire

August 18, 2026

Dsm-firmenich reports H1 2026 results

July 30, 2026

Dsm-firmenich receives FDA approval on PARSOL® Shield, a new sun protection ingredient for the U.S.

June 10, 2026

Dsm-firmenich shares commence trading on SIX Swiss Exchange, establishing dual listing with Euronext Amsterdam

May 21, 2026

dsm-firmenich shareholders approve all resolutions at Annual General Meeting 2026

May 7, 2026

dsm-firmenich Q1 2026 trading update

May 6, 2026

Weekly progress on share repurchase program to cover share plans and reduce capital

April 28, 2026

dsm-firmenich outlines action plan at Investor Event to accelerate performance, following completion of transformation

March 12, 2026

dsm-firmenich announces share repurchase program to cover share plans and reduce capital

March 12, 2026

dsm-firmenich cancels its shares following completion of its €1.08 billion share repurchase program

February 26, 2026

dsm-firmenich publishes 2025 Integrated Annual Report

February 20, 2026

dsm-firmenich issues €1.5 billion long-term bonds

February 17, 2026

dsm-firmenich reports full year 2025 results

February 12, 2026

dsm-firmenich provides preliminary comparative figures following the announced divestment of Animal Nutrition & Health (ANH)

February 9, 2026

dsm-firmenich announces agreement to divest Animal Nutrition & Health to CVC Capital Partners

February 9, 2026

dsm-firmenich appoints Nikeisha van Sleeuwen as Chief Human Resources Officer

January 14, 2026

Calls in 2026

Decks in 2026